OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
54 hedge funds and large institutions have $40.2M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$465K | |
| 3 | +$424K | |
| 4 |
Primecap Management
Pasadena,
California
|
+$286K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$205K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$654K | |
| 3 | -$507K | |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$483K |
| 5 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$351K |